Gadicke Ansbert

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Gadicke Ansbert
✚
CIK #0001134655
EDGAR Form CIK 2011 - 2026
3 [0001134655]
4 [0001134655]
5 [0001134655]
Form 3/4/5 Subject 2011 - 2026
Oncology Impact Private Investment Fund 2 LP
MPM Asset Management LLC
Gadicke Ansbert
Aktis Oncology Inc
Oncology Impact Fund Cayman Management LP
MPM Oncology Innovations Fund LP
Werewolf Therapeutics Inc
MPM BioImpact LLC
UBS Oncology Impact Fund LP
MPM Oncology Innovations Fund GP LLC
iTeos Therapeutics Inc
MPM BioVentures 2014 LP
Entrada Therapeutics Inc
MPM BioVentures 2014 GP LLC
Foley Todd
MPM BioVentures 2018 B LP
Evnin Luke
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM Asset Management Investors BV2018 LLC
MPM BioVentures 2014 B LP
TCR2 Therapeutics Inc
Cullinan Therapeutics Inc
Kalaris Therapeutics Inc
Repare Therapeutics Inc
MPM Oncology Impact Management GP LLC
Harpoon Therapeutics Inc
Oncorus Inc
Dyne Therapeutics Inc
MPM BioVentures 2018 LP
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
MPM BioVentures V LP
MPM BioVentures V GP LLC
Rhythm Pharmaceuticals Inc
MPM BioVentures V LLC
MPM Asset Management Investors BV5 LLC
Radius Health Inc
Chiasma Inc
MPM Asset Management Investors BV4 LLC
Kailian Vaughn M
MPM BioVentures IV LLC
Syndax Pharmaceuticals Inc
MPM BioVentures IV Strategic Fund LP
MPM BioVentures IV GP LLC
Scopa James Paul
MPM BioVentures IV QP LP
MPM BioVentures IV GmbH & Co Beteiligungs KG
Avalo Therapeutics Inc
TriVascular Technologies Inc
Aratana Therapeutics Inc
Epizyme Inc
Histogen Inc
Vander Vort John
Pacira BioSciences Inc
Humanigen Inc
Galakatos Nicholas
Wheeler Kurt
Simon Nicholas J III
Steinmetz Michael
Henner Dennis
Somaxon Pharmaceuticals Inc
Verastem Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Buy 1,112,777 $18.00 20,029,986
Aktis Oncology Inc AKTS
Series Seed Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 5,000,000 $0.00
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 6,000,000 $0.00
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 22,500,000 $0.00
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 1,314,262
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 5,914,197
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 1,577,119
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-04 Sell 83,230 $0.97 80,733
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-03 Sell 57,225 $0.87 49,786
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-02 Sell 59,277 $0.89 52,757
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-01 Sell 60,917 $0.94 57,262
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-28 Sell 20,277 $0.99 20,074
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-26 Sell 60,733 $0.98 59,518
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-25 Sell 42,533 $0.92 39,130
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-24 Sell 88,802 $0.98 87,026
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-21 Sell 64,331 $0.83 53,395
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-20 Sell 41,152 $0.89 36,625
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-19 Sell 66,324 $0.94 62,345
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-18 Sell 52,627 $0.93 48,943
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-17 Sell 57,061 $0.95 54,208
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com